Management of Syphilis with Rising Titers After Treatment
A patient with syphilis treated one year ago with initial RPR titers of 1:64 and current titers of 1:132 should undergo cerebrospinal fluid (CSF) examination and be retreated for latent syphilis, even if the CSF examination is negative. 1
Assessment of Treatment Failure
- This represents a greater than fourfold increase in titers (from 1:64 to 1:132), which meets the criteria for serological treatment failure according to CDC guidelines 1
- A fourfold increase in titers after treatment suggests either reinfection or treatment failure, both requiring intervention 1
- When titers increase fourfold after initial therapy, a CSF examination is mandatory to rule out neurosyphilis 1
Recommended Management Algorithm
Perform CSF examination immediately to evaluate for neurosyphilis 1
- Look for CSF abnormalities such as elevated protein, pleocytosis, or positive VDRL test 1
Clinical evaluation for signs/symptoms of:
Retreatment regardless of CSF results:
- Even if CSF examination is negative, retreatment for latent syphilis should be initiated 1
- For patients without neurosyphilis: Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM each at 1-week intervals 1
- For patients with neurosyphilis: Follow neurosyphilis treatment protocol (typically aqueous crystalline penicillin G) 1
For penicillin-allergic patients:
Follow-Up After Retreatment
- Repeat quantitative nontreponemal serologic tests at 6,12, and 24 months after retreatment 1
- Expect at least a fourfold decline in titers within 12-24 months after retreatment 1
- If titers fail to decline appropriately after retreatment, consider additional CSF examination 1
Important Considerations
- The significant rise in titer (from 1:64 to 1:132) is concerning and requires immediate intervention, as it exceeds the fourfold increase threshold that defines treatment failure 1
- HIV testing should be performed if not already done, as HIV status can affect syphilis treatment response 1, 3
- Low CD4 counts (<350 cells/ml) are associated with higher rates of serological failure after treatment 3
- Even with appropriate treatment, complete seroreversion is uncommon - only about 17% of patients achieve this by 12 months 4
Common Pitfalls to Avoid
- Don't wait and observe: A fourfold increase in titers requires immediate action, not watchful waiting 1
- Don't skip CSF examination: This is essential when titers increase fourfold after treatment 1
- Don't assume reinfection without investigation: While reinfection is possible, treatment failure must be ruled out through proper evaluation 5
- Don't expect rapid seroreversion: Even with successful retreatment, titers may decline slowly and complete seroreversion is uncommon 4